AI @ HLTH Series : Next-gen engagement and AI for clinical trial patients and sites

In this episode, host Sandy Vance chats with Sharmin Nasrullah, the GM of Life Sciences Clinical. In this insightful conversation, they explore how AI and data are revolutionizing the landscape of clinical trials, paving the way for holistic and personalized approaches in the pharmaceutical industry. Tune in to discover the innovations shaping next-generation trials and how organizations are leveraging technology to enhance patient experiences and outcomes.

In this episode, they talk about:

• The birth of Salesforce’s Life Science Cloud platform
• What Salesforce is doing in the clinical trial space
• Understanding recruitment processes in clinical trials
• How Salesforce eases the research burdens for sponsors and sites
• Patient information transfer from providers to Salesforce Life Science Cloud Platform
• The impact of AI advancements on the clinical trial process
• Systems replaced by Salesforce’s cloud application
• How the cloud system matches patients with clinical trials

A Little About Sharmin:

Sharmin Nasrullah is the GM of Life Sciences, Clinical at Salesforce. As General Manager, Sharmin leads the overall product strategy and go-to-market strategy for the R&D clinical suite of applications and products on Life Sciences Cloud, leveraging the best of the Salesforce platform and ushering in a new wave of innovations in clinical development.

Before Salesforce, Sharmin held several leadership positions across the industry including leading digital health enterprise architecture at AstraZeneca, leading product and sales strategy in clinical data management at Veeva Systems, and leading clinical operations at Stanford University’s academic research organization.

Sharmin holds a Master of Science in Bioengineering from Stanford University and a Bachelor of Science in Electrical Engineering from the University of Waterloo.